Actively Recruiting
Heart Rate Variability in Benign Paroxysmal Positional Vertigo
Led by Istanbul Aydın University · Updated on 2026-04-16
104
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder. Although the pathophysiology of BPPV is mainly attributed to the displacement of otoconia within the semicircular canals, recent studies suggest that psychological stress and anxiety may be associated with the onset or recurrence of the disease. However, the biological mechanisms underlying this relationship remain poorly understood, and objective evaluation of autonomic nervous system function in patients with BPPV is limited. Heart rate variability (HRV) is a non-invasive method widely used to assess autonomic nervous system activity. Short-term HRV measurements provide information about autonomic balance and vagal tone. In particular, parameters such as the root mean square of successive differences (RMSSD) and the coefficient of variation of RR intervals (COV RR/R) are considered indicators of parasympathetic activity. The aim of this prospective case-control study is to evaluate vagal tone in patients with BPPV using short-term HRV analysis and to compare the findings with age-, sex-, and body mass index-matched healthy controls. Participants will undergo standardized HRV measurements at rest and during controlled breathing. Perceived stress levels will also be assessed using the Perceived Stress Scale (PSS-10). The primary outcomes of the study are RMSSD and the coefficient of variation of RR intervals (COV RR/R), obtained from short-term HRV recordings. These parameters will be compared between BPPV patients and healthy controls, and their associations with perceived stress levels will also be explored. The findings of this study may provide insights into the role of autonomic regulation and stress-related mechanisms in the pathophysiology of BPPV.
CONDITIONS
Official Title
Heart Rate Variability in Benign Paroxysmal Positional Vertigo
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Clinical diagnosis of benign paroxysmal positional vertigo (BPPV) confirmed by positional testing with positional nystagmus (BPPV group)
- No known history of cardiac disease (BPPV group)
- Ability and willingness to provide written informed consent
- Age 18 years or older (Healthy control group)
- No history of vertigo or vestibular disorder (Healthy control group)
- Age- and sex-matched to BPPV group (Healthy control group)
- No known history of cardiac disease (Healthy control group)
You will not qualify if you...
- Younger than 18 years
- Inability to provide informed consent or impaired mental capacity
- Known arrhythmia, heart failure, ischemic heart disease, or other significant cardiac disorder
- Use of medications affecting heart rate variability including beta-blockers, calcium channel blockers, antiarrhythmic drugs, digoxin, corticosteroids, sympatholytic agents, or psychotropic medications
- Active infection or systemic inflammatory disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medicalpark Florya Hospital
Istanbul, Küçükçekmece, Turkey (Türkiye), 34295
Actively Recruiting
Research Team
D
Dastan Temirbekov, assistan professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here